Indivior PLC Ordinary Shares
Price & Volume
Stats
See moreOpen | $10.54 |
Previous Close | $10.58 |
Day Range | $10.45-$10.78 |
52W Range | $7.33-$23.22 |
Market Cap | $1.3B |
Shares Short | 597,804 |
Financials
See moreRevenue (12 Mos) | $1.1B |
Revenue Growth (YoY) | 13.3% |
Gross Profit (12 Mos) | $742M |
Diluted EPS | -$0.03 |
News
See moreYahoo Finance • 2 months ago
Indivior's SUBLOCADE® Rapid Induction/Alternative Injection Site Prior Approval Supplement (PAS) Receives FDA Priority Review
Yahoo Finance • 2 months ago
Top 3 Health Care Stocks That May Explode This Month
Yahoo Finance • 3 months ago
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
Yahoo Finance • 6 months ago
Indivior to Host Analyst Teach-in Event in New York City; Reconfirms Full Year 2024 Guidance
About
CEO | Mr. Mark Crossley |
CFO | Mr. Ryan Preblick |
Address | 10710 Midlothian Turnpike, North Chesterfield, VA, United States, 23235 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 1,000 |
